Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.
Published April 10, 2013 · Recall initiated: March 19, 2013
Summary
FDA records drug Class III recall D-238-2013, published April 10, 2013 and initiated March 19, 2013. Recalling firm: Dr. Reddy'S Laboratories; Status: Terminated; Reported quantity: 117,546 bottles; Lot: Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
What to do
Voluntary: Firm initiated · Letter
Get an email if TIZANIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr. Reddy'S Laboratories
- Distributor
- Nationwide and Puerto Rico.
- UPC
- 0355111180104
- Lot
- Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, SrikakulamJanuary 17, 2024
- FDATizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories LimitedJuly 26, 2023
- FDATizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottlesJuly 12, 2023
- FDATizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only,July 12, 2023
- FDACLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVAApril 10, 2013
- FDAAmoxicillin for Oral Suspension, 125mg/5mL, a) 80 mL (NDC 43598-222-80); b) 100mL, (NDC 43598-222-52); c)150April 10, 2013
Questions about this recall
Was Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15. recalled?
Yes. FDA published recall D-238-2013 on April 10, 2013. Reported hazard: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.